July 24, 2026
10 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny for having several members with conflicts of interest, met July 23 and 24 to discuss peptides.
July 24, 2026
10 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced…

Over 2-day meeting, six of seven peptides are recommended for adding to bulk compounding list

A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back…

An FDA advisory committee has recommended that three peptide drugs that were previously restricted because of potential safety…

This week, the FDA's Pharmacy Compounding Advisory Committee largely voted yes to allowing several peptides be produced by…

Ahead of an FDA advisory committee meeting to discuss lifting restrictions on seven popular peptides, agency reviewers have…

FDA panel reviewing some peptides to consider loosening regulations for unapproved therapies

FDA Panel Finds a Peptide It Doesn't Like

FDA’s Review Of Peptides Signals A Growing Public Health Challenge

UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm

FDA Panel Clears the Way for 6 Banned Peptides. Here's What They're Claimed to Do

An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition

FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?

Is a peptide boom underway? FDA advisers vote for looser rules

FDA panel considers easing peptide restrictions

FDA Set To Review Safety And Access To Peptides: What You Need To Know